Does Medicare cover HER2-Positive Breast Cancer treatment

Medicare Coverage for HER2-Positive Breast Cancer Treatment

This is an important question, and the answer is: yes, Medicare generally covers HER2-positive breast cancer treatments, but coverage depends on several factors including which specific drug you're prescribed, whether it's FDA-approved, and how it's being used.

What Medicare Typically Covers

Medicare covers FDA-approved HER2-targeted therapies that are considered standard of care for HER2-positive breast cancer. This includes:

• Trastuzumab (Herceptin) - the foundational anti-HER2 monoclonal antibody
• Pertuzumab (Perjeta) - often used in combination with trastuzumab
• Trastuzumab deruxtecan (Enhertu) - an antibody-drug conjugate (a newer class of drugs that combines an antibody with a chemotherapy agent) that was recently FDA-approved and has shown remarkable results

According to the webinar "Clinical Guidance from Proteomics," trastuzumab deruxtecan represents a significant advancement, particularly for patients with HER2 low expression (1+ or 2+ on immunohistochemistry testing). In clinical trials, this drug showed an overall survival of 24 months compared to 17 months for chemotherapy alone in the HER2 low population.

Important Coverage Considerations

Off-Label Use and Prior Authorization: The webinar "Novel Therapies and New Directions in Pancreas Cancer, 2024" discusses a real-world case where a patient with HER2-positive cancer was being directed into an older treatment combination, even though newer options like Enhertu were available. This illustrates an important point: even when newer, more effective drugs exist, getting Medicare approval may require:

1. Prior authorization - your doctor must request approval before treatment begins
2. Documentation of medical necessity - your oncologist needs to justify why this specific drug is appropriate for YOUR case
3. Demonstration that standard treatments have failed (in some cases)

Off-Label Treatment: If your doctor prescribes an FDA-approved drug for a use not specifically approved by the FDA (called "off-label" use), Medicare may still cover it if there's clinical evidence supporting its use. However, this often requires additional documentation and may take longer to approve.

Real-World Coverage Challenges

The webinars highlight some practical realities about coverage:

• Community vs. Academic Centers: According to "The Personalization Conundrum," academic cancer centers sometimes have more flexibility to pursue newer treatments because they have different financial incentive structures than community practices. A patient at an NCI-designated comprehensive cancer center was able to access an off-label HER2 treatment when Medicare wouldn't initially cover it—the drug manufacturer provided it free of charge.

• Reimbursement Variations: There's a significant difference between whether a drug is available and whether it's reimbursed. Insurance companies may cover the drug cost but not the administration (infusion) costs, creating gaps in coverage.

What You Should Do

Questions to ask your Medicare plan and oncologist:

1. "Is [specific drug name] covered under my Medicare plan for my diagnosis?"
2. "Will this require prior authorization, and how long does that process typically take?"
3. "If my insurance denies coverage, what is the appeals process, and will you help me appeal?"
4. "Are there patient assistance programs from the drug manufacturer if coverage is denied?"
5. "If this drug is prescribed off-label, what evidence supports its use for my specific situation?"

Additional Resources

According to the webinars, if you encounter coverage barriers:

• Ask your oncology team about patient assistance programs directly from pharmaceutical manufacturers
• Request that your doctor document the clinical rationale for the treatment choice
• Consider working with a patient advocate or navigator at your cancer center who specializes in insurance issues
• If denied, don't hesitate to appeal—the webinars emphasize that persistence in these situations can make a difference

Important Note: Coverage policies change frequently, and your specific Medicare plan (Original Medicare vs. Medicare Advantage) may have different rules. Always verify current coverage with your plan before starting treatment.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.